This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prince, H. E.
Right arrow Articles by Seaton, B. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prince, H. E.
Right arrow Articles by Seaton, B. L.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, April 2009, p. 587-588, Vol. 16, No. 4
1071-412X/09/$08.00+0     doi:10.1128/CVI.00462-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Frequency of Missed Cases of Probable Acute West Nile Virus (WNV) Infection when Testing for WNV RNA Alone or WNV Immunoglobulin M Alone{triangledown}

Harry E. Prince,* Jan Calma, Tiffany Pham, and Brent L. Seaton

Focus Diagnostics, Inc., Cypress, California 90630

Received 8 December 2008/ Returned for modification 11 January 2009/ Accepted 9 February 2009

To estimate the frequency of missed cases of acute West Nile virus (WNV) infection if only WNV RNA or immunoglobulin M (IgM) testing is requested, we measured IgM in specimens negative for RNA and vice versa. Whereas 6 (5.5%) of 110 RNA-negative sera were IgM positive, only 3 (1.0%) of 299 IgM-negative sera were RNA positive (P < 0.05). Similarly, 11 (7.8%) of 141 RNA-negative cerebrospinal fluid specimens (CSF) were IgM positive, but 0 (0%) of 118 IgM-negative CSF were RNA positive (P < 0.05). WNV infections may be missed if only RNA or IgM testing is requested, with a higher frequency of missed cases if only RNA testing is requested.


* Corresponding author. Mailing address: Focus Diagnostics, Inc., 5785 Corporate Avenue, Cypress, CA 90630. Phone: (714) 822-2457. Fax: (714) 821-3364. E-mail: hprince{at}focusdx.com

{triangledown} Published ahead of print on 18 February 2009.


Clinical and Vaccine Immunology, April 2009, p. 587-588, Vol. 16, No. 4
1071-412X/09/$08.00+0     doi:10.1128/CVI.00462-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.